If you purchased Metacrine Inc. securities and would like to join the action, please click "Join This Action" below.
MTCR STOCK ALERT: HALPER SADEH LLP IS INVESTIGATING WHETHER THE MERGER OF METACRINE INC. IS FAIR TO SHAREHOLDERS
September 6, 2022.
New York, New York—Halper Sadeh LLP, an investor rights law firm, is investigating whether the merger of Metacrine Inc. (NASDAQ: MTCR) and Equillium, Inc. is fair to Metacrine shareholders.
The investigation concerns whether Metacrine and its board violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to, among other things: (1) obtain the best possible consideration for Metacrine shareholders; and (2) disclose all material information necessary for Metacrine shareholders to adequately assess and value the merger consideration. On behalf of Metacrine shareholders, Halper Sadeh LLP may seek increased consideration for shareholders, additional disclosures and information concerning the proposed transaction, or other relief and benefits.
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.